4 results match your criteria: "Jinan Central Hospital Affiliated to Shandong UniversityJinan[Affiliation]"
Am J Cancer Res
January 2018
Department of Oncology, Jinan Central Hospital Affiliated to Shandong UniversityJinan 250013, Shandong, P. R. China.
New immunotherapeutic approaches are urgently needed for gastric cancer due to its poor survival and unsatisfactory treatment. Here we applied the humanized chA21 scfv based chimeric antigen receptor (CAR) modified T cells approach to the HER2 overexpressing gastric cancer treatment. The chA21-4-1BBz CAR T cells specifically exerted Th1 skewed cytokine response and efficient cytolysis of HER2 overexpressing human gastric cancer cells .
View Article and Find Full Text PDFAm J Cancer Res
November 2017
Department of Oncology, Jinan Central Hospital Affiliated to Shandong UniversityJinan, Shandong Province, China.
The functional phenotypes (M1 and M2) of tumor-associated macrophages (TAMs) are influenced by the tumor microenvironment (TME) and contribute greatly to the development of non-small cell lung cancer (NSCLC). However, the molecular mechanisms for TAM polarization remain unclear. Angiopoietin-like protein 2 (Angptl2) is involved in tumor progression.
View Article and Find Full Text PDFFront Pharmacol
August 2017
Central Laboratory, Jinan Central Hospital Affiliated to Shandong UniversityJinan, China.
Nicotine and nicotinic acetylcholine receptors (nAChRs) are considered to be involved in lung cancer risk, onset and progression, but their precise physiological roles in these contexts remain unclear. Our previous studies suggested that α5-nAChR mediates nicotine-induced lung cancer cell proliferation, migration, and invasion . In this study, we aimed to determine the role of α5-nAChR in the development and progression of non-small cell lung cancer (NSCLC).
View Article and Find Full Text PDFAm J Cancer Res
September 2016
Central Laboratory, Jinan Central Hospital Affiliated to Shandong UniversityJinan 250013, People's Republic of China; Shandong Province Key Lab of Tumor Target Molecule, Jinan Central Hospital Affiliated to Shandong UniversityJinan 250013, People's Republic of China.